Public Employees Retirement System of Ohio Makes New $7.22 Million Investment in Haleon PLC Sponsored ADR $HLN

Public Employees Retirement System of Ohio bought a new stake in shares of Haleon PLC Sponsored ADR (NYSE:HLN) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 773,503 shares of the company’s stock, valued at approximately $7,217,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. IHT Wealth Management LLC increased its position in Haleon by 6.9% during the fourth quarter. IHT Wealth Management LLC now owns 16,205 shares of the company’s stock valued at $164,000 after acquiring an additional 1,049 shares during the last quarter. National Bank of Canada FI boosted its position in Haleon by 6.7% in the third quarter. National Bank of Canada FI now owns 17,385 shares of the company’s stock worth $156,000 after purchasing an additional 1,099 shares during the last quarter. Oppenheimer & Co. Inc. boosted its position in Haleon by 4.7% in the fourth quarter. Oppenheimer & Co. Inc. now owns 24,744 shares of the company’s stock worth $250,000 after purchasing an additional 1,100 shares during the last quarter. Cary Street Partners Financial LLC grew its stake in shares of Haleon by 20.1% during the 2nd quarter. Cary Street Partners Financial LLC now owns 6,646 shares of the company’s stock valued at $69,000 after purchasing an additional 1,113 shares during the period. Finally, Advisory Services Network LLC grew its stake in shares of Haleon by 7.1% during the 3rd quarter. Advisory Services Network LLC now owns 17,431 shares of the company’s stock valued at $156,000 after purchasing an additional 1,155 shares during the period. 6.67% of the stock is owned by institutional investors.

Haleon Stock Up 0.6%

HLN stock opened at $10.09 on Wednesday. The business’s 50-day moving average price is $9.85 and its 200-day moving average price is $9.78. The stock has a market cap of $44.38 billion, a P/E ratio of 25.87, a PEG ratio of 2.01 and a beta of 0.12. The company has a quick ratio of 0.52, a current ratio of 0.69 and a debt-to-equity ratio of 0.38. Haleon PLC Sponsored ADR has a twelve month low of $8.65 and a twelve month high of $11.28.

Haleon Cuts Dividend

The company also recently declared a dividend, which will be paid on Thursday, September 17th. Shareholders of record on Friday, August 14th will be issued a dividend of $0.0642 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a yield of 132.0%. Haleon’s payout ratio is currently 30.77%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. Morgan Stanley reiterated an “overweight” rating on shares of Haleon in a research note on Thursday, August 6th. Jefferies Financial Group reaffirmed a “buy” rating on shares of Haleon in a report on Monday, August 24th. Rothschild & Co Redburn downgraded shares of Haleon from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, June 16th. Wall Street Zen upgraded shares of Haleon from a “hold” rating to a “buy” rating in a research note on Sunday, July 12th. Finally, Zacks Research raised shares of Haleon from a “strong sell” rating to a “hold” rating in a research report on Wednesday, August 19th. Two analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy”.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.